Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas-Reference-Cited by-同舟云学术

Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas

Published:2019-03-01 Issue:6 Volume:20 Page:843-854
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Moes-Sosnowska Joanna¹^ORCID,Rzepecka Iwona K.²^ORCID,Chodzynska Joanna³,Dansonka-Mieszkowska Agnieszka²^ORCID,Szafron Lukasz M.¹^ORCID,Balabas Aneta⁴^ORCID,Lotocka Renata²,Sobiczewski Piotr⁵,Kupryjanczyk Jolanta²^ORCID

Affiliation:

1. Department of Immunology, Maria Sklodowska-Curie Institute – Oncology Center, Warsaw, Poland

2. Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie Institute – Oncology Center, Warsaw, Poland

3. Laboratory of Bioinformatics and Biostatistics, Maria Sklodowska-Curie Institute – Oncology Center, Warsaw, Poland

4. Department of Genetics, Maria Sklodowska-Curie Institute – Oncology Center, Warsaw, Poland

5. Department of Gynecologic Oncology, Maria Sklodowska-Curie Institute – Oncology Center, Warsaw, Poland

Funder

Polish Ministry of Science and Higher Education

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://tandfonline.com/doi/pdf/10.1080/15384047.2019.1579955

Reference85 articles.

1. Global cancer statistics

2. Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

3. A new standard of care for treatment of ovarian cancer

4. New heteronuclear gold(I)–platinum(II) complexes with cytotoxic properties: Are two metals better than one?

5. Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FANCD2 expression affects platinum response and further characteristics of high grade serous ovarian cancer in cells with different genetic backgrounds;Experimental and Molecular Pathology;2024-08

2. Clinical Validation of the Somatic FANCD2 Mutation (c.2022-5C>T) as a Novel Molecular Biomarker for Early Disease Progression in Chronic Myeloid Leukemia: A Case–Control Study;Hematology Reports;2024-07-08

3. Characteristics of germline DNA damage response gene mutations in ovarian cancer in Southwest China;Scientific Reports;2024-03-20

4. Pancancer analysis of the prognostic and immunological role of FANCD2: a potential target for carcinogenesis and survival;BMC Medical Genomics;2024-03-05

5. MORE interpretable multi-omic regulatory networks to characterize phenotypes;2024-01-29